688317 之江生物
按盤價 
16.020 +1.190 (+8.024%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.702 | -3.411 | 18.941 | 28.678 | 91.620 |
| 總資產報酬率 ROA (%) | 0.663 | -3.104 | 16.898 | 24.731 | 73.925 |
| 投入資產回報率 ROIC (%) | 0.697 | -3.368 | 18.639 | 28.019 | 55.708 | 邊際利潤分析 |
| 銷售毛利率 (%) | 75.673 | 65.123 | 51.645 | 62.483 | 73.934 |
| 營業利潤率 (%) | 61.305 | -54.495 | 39.005 | 44.636 | 54.171 |
| 息稅前利潤/營業總收入 (%) | -27.235 | -88.002 | 34.123 | 44.281 | 55.329 |
| 淨利潤/營業總收入 (%) | 52.525 | -49.887 | 32.682 | 37.573 | 45.416 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 108.354 | -7.354 | 94.693 | 98.460 | 100.301 |
| 價值變動淨收益/利潤總額(%) | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| 營業外收支淨額/利潤總額(%) | 0.079 | 4.555 | -0.652 | -0.530 | -0.222 | 償債能力分析 |
| 流動比率 (X) | 16.221 | 13.383 | 7.463 | 8.687 | 4.107 |
| 速動比率 (X) | 14.959 | 12.311 | 6.501 | 7.954 | 3.765 |
| 資產負債率 (%) | 5.085 | 6.118 | 11.456 | 10.042 | 22.184 |
| 帶息債務/全部投入資本 (%) | 0.383 | 0.499 | 1.184 | 1.069 | -- |
| 股東權益/帶息債務 (%) | 25,913.427 | 19,878.514 | 8,310.048 | 9,211.110 | 4,432.473 |
| 股東權益/負債合計 (%) | 1,866.616 | 1,534.554 | 772.931 | 895.781 | 350.766 |
| 利息保障倍數 (X) | 0.307 | 2.847 | -7.370 | -370.356 | 43.275 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 176.733 | 216.341 | 34.287 | 39.719 | 0.000 |
| 存貨周轉天數 (天) | 1,800.180 | 1,425.308 | 128.576 | 102.473 | 0.000 |
| 備註： | 即時報價更新時間為 29/04/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
